Dx whistleblower to share gains; Merck Serono launches latest Eeva test from Auxogyn;

@FierceMedDev: UPDATED: American Heart Association guidelines encourage use of stent retrievers to treat stroke. Report | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Microchips Biotech partners with Teva on wireless drug delivery, announces new CEO, raises $18M in financing. FierceDrugDelivery story | Follow @VarunSaxena2

@EmilyWFierce: Pay friends to quit smoking with Pfizer's new digital tool. FiercePharmaMarketing article | Follow @EmilyWFierce

> Rehabilitation and physical therapy product maker Dynatronics ($DYNT) has raised $4 million in a private placement led by Prettybrook Partners to support organic growth and strategic acquisitions. More

> Merck Serono launched the latest versions of the Eeva (Early Embryo Viability Assessment) Test with the Xtend Algorithm to aid in embryo assessment within assisted reproductive treatment (ART). It gained rights to market the test in Europe and Canada from Auxogyn. More

> A California whistleblower who was awarded $241M in a lawsuit against Quest Diagnostics ($DGX) and Unilab must pay $7 million to a New York whistleblower who lost a similar suit. Story

Biotech News

@FierceBiotech: FierceBiotech Radio on the cost of CAR-T, the future of Zoetis, and gentrification in Kendall Square. Listen | Follow @FierceBiotech

@JohnCFierce: Trending: Is Celgene killing the traditional biotech partnering formula? Editor's corner | Follow @JohnCFierce

@DamianFierce: Join us as we search for the Amar'e Stoudemire of immuno-oncology. FierceBiotech Radio  | Follow @DamianFierce

> Purdue pulls out of FDA panel on abuse-deterrent OxyContin just days before meeting. Report

> Whittled down to biotech size, AstraZeneca's antibiotics crew starts over as Entasis. News

Pharma News

@FiercePharma: UPDATED: Bayer, J&J touting Xarelto trial data to counteract Eliquis surge. More | Follow @FiercePharma

@EricPFierce: Join us July 8 for a Twiiter chat on #sustainedrelease with BASF expert Thorsten Cech. Details are here. | Follow @EricPFierce

@CarlyHFierce: Not gonna lie, I purposely use the phrase "the Illinois pharma" every time I write about an Illinois pharma. | Follow @CarlyHFierce

> Biogen to build $1B plant, add 400 jobs in Switzerland. Story

> Sworn to end doc payments by 2016, GSK still shelled out $15M last year. More

Biotech Research News

> Researchers highlight a nuanced approach to flagging early Alzheimer's. Article

> Antibody 'cocktail' looks promising against deadly Marburg virus. News

> Salk investigators develop a new autophagy combo drug to starve tumors. More

> Dual cancer role for Daple attracts research team at UC San Diego. Article

> UCL team sees promise in mouse study of pancreatic tumor-targeting compound. Story

Diagnostics News

> Cinven snatches up Synlab for $1.96B to beef up in diagnostics. More

> Luxembourg's Eurofins rides JV diagnostics wave with Emory University deal. Editor's corner

> NIH provides Great Basin Scientific and BYU $5M+ to develop rapid test for CRE. Story

> Illumina unveils plans for new European HQ and science center. Item

> Qiagen launches Germany-based JV aimed at companion Dx. Article

Pharma Marketing News

> Feds demand $3.4B in damages, fines in Novartis kickback case. Story

> Latest Sunshine Act bombshell: $6.5B in doc-and-hospital payments last year. More

> House bill would force FDA to ease up on social media. Article

> Pay friends to quit smoking with Pfizer's new digital tool. Story

> Bayer, J&J touting Xarelto trial data to counteract Eliquis surge. Report